- Developing and evaluating smoking cessation treatments -
30TH - 31ST JANUARY 2008, BSG CONFERENCE CENTRE, LONDON, UK
Tobacco consumption remains the most important avoidable cancer risk and smoking causes 90% of all lung cancers. The vast majority of cigarette smokers who try to quit ultimately fail because of high relapse rates. Our first Smoking Cessation could not be more timely. With the first prescription medication approved in almost a decade for smoking cessation and recent smoking bans in countries, especially in England. The anti-smoking pipeline looks promising with a total of 17 drugs with new targets. The launch of new therapies, such as the vaccines and MAO inhibitors, expected to hit the market in late 2009 and early 2010 will have a major impact on the overall drive of the market in terms of revenue. As health authorities seek to reduce overall healthcare expenditure on smoking related disorders. The Smoking Cessation conference will provide the ideal strategic forum for researchers, clinicians, pharma, and biotech to examine current and future smoking cessation therapies, and assess the factors influencing the market, from new product developments to distribution and pricing issues.
To download the free brouchure, please visit :
http://www.bharatbook.com/
Reasons to register today :
1. Explore the prospects for long term efficacy of new classes of no nicotinic drugs in development
2. Identify novel therapeutic targets to improve smoking cessation
3. Examine potential market opportunities for new anti-smoking products
4. Discuss the regulatory considerations for therapeutic vaccination
5. Increase the cost-effectiveness and benefi ts of smoking cessation aids
6. Hear from expert figures of all areas of the industry, collaborating and sharing knowledge at one venue
Who will be there?
Companies :
Pharmaceutical and biotech companies
Academics
Regulatory organisations
Trade organisations
Healthcare professionals
VPs, Directors, Heads and Managers of :
Research and Development
Business Development
Commerical development
Clinical Trials
Clinical Pharmacology
Drug Delivery
Smoking Cessation/ Anti-smoking products
Outcomes Research
Pricing
Reimbursement and Access
Marketing
Product management
For more information about this event, please visit :
http://www.bharatbook.com/
To download the free brouchure, please visit :
http://www.bharatbook.com/
